[RCKT] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[RCKT] Rocket Pharmaceuticals, Inc.
Announcement Date
05-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 14.64%
YoY- -26.60%
Quarter Report
RCKT's Result
RCKT's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 10,312 0 0 0 0 0 0 -
PBT -59,660 -61,899 -65,701 -58,335 -66,723 -57,756 -54,402 6.32%
Tax 1,626 -1,759 3,524 -3,391 -2,358 -732 192 313.86%
NP -59,660 -61,899 -65,701 -54,944 -64,365 -57,024 -54,594 6.07%
Tax Rate - - - - - - - -
Total Cost 69,972 61,899 65,701 54,944 64,365 57,024 54,594 17.93%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -578.55 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.64 -0.75 -0.82 -0.69 -0.88 -0.86 -0.83 -15.87%
EPS Diluted -0.64 -0.75 -0.82 -0.69 -0.88 -0.86 -0.83 -15.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.